XFORX4 Pharmaceuticals, Inc.
4.040USD-2.88%Mkt Cap: 400.55M $P/E: 2.833d ago
X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an ora…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap400.55M $
Enterprise Value268.82M $
Revenue (TTM)15.85M $
Gross Profit29.36M $
Net Income (TTM)-79.20M $
Revenue/Share0.1560 USD
Last Price4.040 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees45
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)2.83
P/E (Forward)-5.34
PEG—
EV/EBITDA-3.40
EV/Revenue16.96
P/S25.21
P/B2.49
EPS (TTM)1.39
EPS (Forward)-0.76
52W Range
2.45067% of range4.830
52W High4.830 USD
52W Low2.450 USD
Profitability
Gross Margin83.60%
Oper. Margin-186.13%
EBITDA Margin0.00%
Profit Margin-225.55%
ROE-42.51%
ROA-27.27%
Growth
Revenue Growth346.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-85.62M $
CapEx (TTM)3.00M $
FCF Margin-336.41%
FCF Yield-13.31%
Net Debt-130.74M $
Net Debt/EBITDA1.65
Balance Sheet
Debt/Equity0.41
Current Ratio11.30
Quick Ratio10.85
Book Value/Sh1.617 USD
Cash/Share2.098 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 14, 2019
Splits
Last Split1:30
Split DateApr 28, 2025
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)11.60 USD
Upside (mean)+187.1%
Target Range10.00 USD – 13.00 USD
$10.00+187.1% to mean$13.00
# Analysts5
Ownership
Shares Out.99.15M
Float62.80M
Insiders0.44%
Institutions100.14%
Short Interest
Short Ratio11.3d
Short % Float7.38%
Short % Out.7.36%
Shares Short7.30M
Short (prev mo.)5.51M
Technical
SMA 504.068 (-0.7%)
SMA 2003.920 (+3.1%)
Beta0.39
S&P 52W Chg18.16%
Avg Vol (30d)710.41K
Avg Vol (10d)876.93K
Technical Indicators
RSI (14)47.0
MACD0.0531
MACD Signal0.0644
MACD Hist.-0.0113
BB Upper4.513 USD
BB Middle4.143 USD
BB Lower3.773 USD
BB Width17.86%
ATR (14)0.2605 USD
Vol Ratio (20d)1.71x